Document is current

Any future updates will be listed below

Glatiramer acetate versus interferon β-1a: rethinking first-line therapy in pediatric-onset multiple sclerosis for greater relapse control

Crossref DOI link: https://doi.org/10.1007/s10072-025-08518-8

Published Online: 2025-10-04

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark